Alpha Sense BI

FEBRUARY 6, 2024

Within the ever-evolving realm of the life sciences industry , fast-paced healthcare investment research plays a crucial role in providing timely insights on valuable opportunities for financial investors.

Research 98

Research Primary Research Due Diligence Competitive Positioning 98

Alpha Sense BI

MARCH 13, 2024

This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. M&A will serve as an avenue for pharmaceutical companies and start-ups to continue making significant advancements in their respective fields.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

DECEMBER 12, 2023

Industry nuances, company culture, leadership styles, competitor interactions—these are facets you can’t necessarily uncover by researching numbers and figures, yet they significantly impact whether or not two companies have the right synergies to succeed. Navigating the cultural challenges around M&A integration is a delicate process.

Due Diligence 52

Due Diligence Primary Research Competitive Intelligence Market Intelligence 52

Alpha Sense BI

MARCH 21, 2024

Newer generation operating models provide actionable expert perspectives that empower informed decision-making while also maximizing your time through technological-driven efficiencies, like artificial intelligence (AI) and generative AI (genAI).

Primary Research 59

Primary Research Due Diligence SWOT Pharmaceutical 59

Alpha Sense BI

DECEMBER 15, 2023

While this technology has long been used in biopharma for small-molecule modeling and drug screening, the applications of AI now reach far beyond those initial purposes—from R&D and drug discovery to manufacturing and commercialization. billion in 2023.

Pharmaceutical 52

Pharmaceutical Algorithm Predictive Analytics Research 52

CIO

JANUARY 3, 2024

Putting aside the fact this is an astronomically high adoption rate for a brand new technology, it’s also an indicator of how risky this space is. When assessing vendors, Rich Products looks at their technology, architecture, business value, and pragmatic perspective. A startup can easily become obsolete in any area of technology.

Alliance 763

Alliance Due Diligence Pharmaceutical Technology 763

Alpha Sense BI

APRIL 12, 2024

Expert interviews are a critical primary research tool that financial professionals often leverage to complete their investment process with last-mile, experiential insights. For example, how do you learn why a major cloud platform lags behind its peers, whether it’s driven by technology or marketplace dynamics?

Primary Research 52

Primary Research Advantage Advantage Research 52